2m 2m 2m 2m 2m 2m 2m
NOVAVAX (NVAX)
NASDAQ
$9.92-$0.06 (-0.64%)
Price as of Nov 12, 2026 8:10 AM EST- $1.6BMarket Cap
- 38.61%1-Year Change
- BiotechnologyIndustry
NOVAVAX (NVAX)
$9.92-$0.06 (-0.64%)
Earnings Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 61.26% | ||
12-Month Momentum | 72.31% | ||
3-Month Risk Adjusted Momentum | 178.10% | ||
12-Month Risk Adjusted Momentum | 107.76% |
True Yield
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.04% |
Financial Health Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |